Anand V.
16
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2014 | 1 |
| 2015 | 4 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Medicina interna | 4 |
| Cáncer | 1 |
| Farmacología | 1 |
| Enfermedad cardiovascular | 1 |
| Medicamento | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 5 |
| Farmacología y terapéutica | 4 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 3 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Prof. Arturo Martí Carvajal MD MSc Ph.D iD | 5 |
| Sola I. | 4 |
| Cardona A.F. | 2 |
| Daniel Simancas-Racines | 2 |
| Gupta P. | 1 |
| Acevedo A.M. | 1 |
| Bangdiwala S.I. | 1 |
Cargando gráfico
Publicaciones del autor
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
ReviewAbstract: Background: Myelofibrosis is a bone marrow disorder characterized by excessive production of reticulPalabras claves:Autores:Anand V., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.Fuentes:scopusTreatment for disseminated intravascular coagulation in patients with acute and chronic leukemia
ReviewAbstract: Background: Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by syPalabras claves:Autores:Anand V., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.Fuentes:googlescopusEculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
ReviewAbstract: Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a chronic, not malignant, disease of the hePalabras claves:Autores:Anand V., Cardona A.F., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.Fuentes:googlescopusProphylactic lidocaine for myocardial infarction
ReviewAbstract: Background: Coronary artery disease is a major public health problem affecting both developed and dePalabras claves:Autores:Anand V., Bangdiwala S.I., Daniel Simancas-Racines, Prof. Arturo Martí Carvajal MD MSc Ph.D iDFuentes:googlescopusImatinib for treating newly diagnosed chronic myeloid leukemia patients
ArticleAbstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To assessPalabras claves:Autores:Acevedo A.M., Anand V., Cardona A.F., Daniel Simancas-Racines, Gupta P., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.Fuentes:scopus